We are confident in this timing and coverage expansion because we believe the administration is highly motivated to increase GLP-1 access before the midterm elections
Compare provider-reviewed options Research Snapshot Provider comparison Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages
The trial enrolled 445 adults with obesity and moderate-to-severe knee osteoarthritis pain (without diabetes), randomized 1:1:1 to 9mg, 12mg, or placebo over 68 weeks
Natural products, particularly probiotics and antioxidants, appear to exert protective effects by stabilizing Nrf2 (175), thereby enhancing the expression of endogenous antioxidant enzymes such as superoxide dismutase (SOD), catalase, and glutathione peroxidase (176)
Glipizide IR tablets are an immediate-release form of the drug